Nebulized platelet-derived extracellular vesicles attenuate chronic cigarette smoke-induced murine emphysema
Translational Research · 2024-07 · 269 · 76-93
DOI: 10.1016/j.trsl.2024.02.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Research, 2024-07. Verfasst von Weixia Xuan und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester 55905, Minnesota.; D…. Hauptthemen laut MEDLINE: Extracellular Vesicles, Pulmonary Emphysema, Mice, Inbred C57BL, Cigarette Smoking. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: Mayo Clinic.
Abstract (Originalsprache)
Chronic obstructive pulmonary disease (COPD) is a prevalent lung disease usually resulting from cigarette smoking (CS). Cigarette smoking induces oxidative stress, which causes inflammation and alveolar epithelial cell apoptosis and represents a compelling therapeutic target for COPD. Purified human platelet-derived exosome product (PEP) is endowed with antioxidant enzymes and immunomodulatory molecules that mediate tissue repair. In this study, a murine model of CS-induced emphysema was used to determine whether nebulized PEP can influence the development of CS-induced emphysema through the mitigation of oxidative stress and inflammation in the lung. Nebulization of PEP effectively delivered the PEP vesicles into the alveolar region, with evidence of their uptake by type I and type II alveolar epithelial cells and macrophages. Lung function testing and morphometric assessment showed a significant attenuation of CS-induced emphysema in mice treated with nebulized PEP thrice weekly for 4 weeks. Whole lung immuno-oncology RNA sequencing analysis revealed that PEP suppressed several CS-induced cell injuries and inflammatory pathways. Validation of inflammatory cytokines and apoptotic protein expression on the lung tissue revealed that mice treated with PEP had significantly lower levels of S100A8/A9 expressing macrophages, higher levels of CD4+/FOXP3+ Treg cells, and reduced NF-κB activation, inflammatory cytokine production, and apoptotic proteins expression. Further validation using in vitro cell culture showed that pretreatment of alveolar epithelial cells with PEP significantly attenuated CS extract-induced apoptotic cell death. These data show that nebulization of exosomes like PEP can effectively deliver exosome cargo into the lung, mitigate CS-induced emphysema in mice, and suppress oxidative lung injury, inflammation, and apoptotic alveolar epithelial cell death.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester 55905, Minnesota.; Department of Respiratory Medicine, Henan Provincial People's Hospital,…
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester 55905, Minnesota.
- Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905, USA.; Van Cleve Cardiac Regenerative Medicine Program, Center for Regenerative Biotherapeutics, Mayo Clinic, Rochester,…
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester 55905, Minnesota.; Touro College of Osteopathic Medicine, New York, NY.
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester 55905, Minnesota.; Department of Respiratory and Critical Care Medicine, West China Hospit…
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester 55905, Minnesota.; Department of Cardiology, Xi-Jing Hospital, Fourth Military Medical Uni…
Förderung
- Mayo Clinic
Zitieren
APA
Xuan, W., Wang, S., Alarcon-Calderon, A., Bagwell, M. S., Para, R., Wang, F., Zhang, C., Tian, X., Stalboerger, P., Peterson, T., Sabbah, M. S., Du, Z., Sarrafian, T., Mahlberg, R., Hillestad, M. L., Rizzo, S. A., Paradise, C. R., Behfar, A., & Vassallo, R. (2024). Nebulized platelet-derived extracellular vesicles attenuate chronic cigarette smoke-induced murine emphysema. Translational Research, 269, 76-93. https://doi.org/10.1016/j.trsl.2024.02.001
Vancouver
Xuan W, Wang S, Alarcon-Calderon A, Bagwell MS, Para R, Wang F, et al. Nebulized platelet-derived extracellular vesicles attenuate chronic cigarette smoke-induced murine emphysema. Translational Research. 2024;269:76-93. doi:10.1016/j.trsl.2024.02.001
BibTeX
@article{Xuan2024,
author = {Xuan, Weixia and Wang, Shaohua and Alarcon-Calderon, Amarilys and Bagwell, Monique Simone and Para, Rachel and Wang, Faping and Zhang, Chujie and Tian, Xue and Stalboerger, Paul and Peterson, Timothy and Sabbah, Michael S and Du, Zeji and Sarrafian, Tiffany and Mahlberg, Ryan and Hillestad, Matthew L and Rizzo, Skylar A and Paradise, Christopher R and Behfar, Atta and Vassallo, Robert},
title = {Nebulized platelet-derived extracellular vesicles attenuate chronic cigarette smoke-induced murine emphysema},
journal = {Translational Research},
year = {2024},
volume = {269},
pages = {76--93},
doi = {10.1016/j.trsl.2024.02.001}
}
EUVIMED